Showing results (111-120 of 126) with videos related to

Sort By:
Pageof 13
Pharmacogenetics and Genomics|September 8, 2016
A novel block at chromosome 12q24.1 is associated with coronary artery disease in Han Chinese populationsFeng Jiang, Han Yan, Chong Wu, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|May 29, 2007
Double-blind, multicenter, active-controlled, randomized clinical trial to assess the safety and efficacy of orally administered nicorandil in patients with stable angina pectoris in ChinaWen-Ling Zhu, Yuan-Dong Shan, Jing-Xuan Guo, et al.
Plos One|January 4, 2018
The safety and efficacy of hybrid ablation for the treatment of atrial fibrillation: A meta-analysisYun-Qiu Jiang, Ying Tian, Li-Jun Zeng, et al.
Zhonghua Xin Xue Guan Bing Za Zhi|July 25, 2013
[Control rate of increased low-density lipoprotein cholesterol levels in cardiology outpatients with coronary heart disease in Beijing]Rong-jing Ding, Chang-sheng Ma, Hong Chen, et al.
Chinese Medical Journal|January 11, 2020
Assessing the association of appropriateness of coronary revascularization and 1-year clinical outcomes for patients with stable coronary artery disease in ChinaShen Lin, Heng Zhang, Chen-Fei Rao, et al.
Coronary Artery Disease|March 4, 2014
Two-year clinical outcomes of patients with overlapping second-generation drug-eluting stents for treatment of long coronary artery lesions: comparison of everolimus-eluting stents with resolute zotarolimus-eluting stentsXiao-tao Li, Hao Sun, Da-peng Zhang, et al.
Chinese Medical Journal|May 21, 2020
Resting heart rate control and prognosis in coronary artery disease patients with hypertension previously treated with bisoprolol: a sub-group analysis of the BISO-CAD studyYun-Dai Chen, Xin-Chun Yang, Vinh Nguyen Pham, et al.
Zhonghua Yi Xue Za Zhi|September 15, 2011
[Evaluation of shensongyangxin capsules in the treatment of paroxysmal atrial fibrillation: a randomized, double-blind and controlled multicenter trial]Ai-hu Wang, Jie-lin Pu, Xiao-yong Qi, et al.
Journal of Geriatric Cardiology : JGC|September 21, 2020
Effects of nicorandil on myocardial infarct size in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: study design and protocol for the randomized controlled trialXiao-Si Jiang, Li-Chao Tian, Zi-Chao Jiang, et al.
The Journal of Invasive Cardiology|October 2, 2007
Reduction in myocardial infarct size by postconditioning in patients after percutaneous coronary interventionXin-Chun Yang, Yu Liu, Le-Feng Wang, et al.
Pageof 13